Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues:    
Total revenues $ 12,829 $ 11,217
Cost of revenues 3,709 3,942
Research and development costs 4,686 2,810
Sales and marketing expenses 5,384 4,756
General and administrative expenses 5,270 4,303
Operating loss (6,220) (4,594)
Other income (expense):    
Other income, net 882 9
Interest expense, net (1,444) (955)
Net loss $ (6,782) $ (5,540)
Net loss per share attributable to common stockholders:    
Basic and diluted $ (0.43) $ (0.42)
Weighted average shares outstanding:    
Basic and diluted 15,849,667 13,155,163
Product Revenues    
Revenues:    
Total revenues $ 8,789 $ 9,796
Service and Other Revenues    
Revenues:    
Total revenues $ 4,040 $ 1,421